The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > GenStar Therapeutics Corporation

GenStar Therapeutics Corporation
AMEX: GNT
Change
symbol:
     
 PROFILE
Maybe some good can come from having a cold. GenStar Therapeutics is developing gene therapy products derived from the cold-causing pathogen adenovirus to treat hemophilia, HIV and AIDS, and prostate cancer. In its "Maximum-Ads" genetically engineered viruses, 97% of the adenovirus is removed and replaced with therapeutic genes (Factor VIII to treat hemophilia and interleukin-3 for prostate cancer). The Maximum-Ads retain the ability of the original virus to infect cells and transfer genetic material. Baxter, which owns almost 10% of the firm, is funding development of its Maxinum-Ad therapy for hemophilia. GenStar is also developing lentiviral gene therapy technology to treat and prevent AIDS.

 COMPETITION
Avigen, Inc. (AVGN)
TRANSGENE S.A. (TRGNY)
Targeted Genetics Corporation (TGEN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.20
1-Yr. Sales Growth: 69.7%
Employees: 53
Revenue per employee: $3,773.58

 KEY PEOPLE
• Robert E. Sobol
    CEO
• Paul D. Quadros
    CFO

 CONTACT INFO
10835 Altman Row
San Diego, CA 92121
US
Phone: 858-450-5949
Fax: 858-642-9173
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001